athenahealth Inc. (ATHN) SVP Sells $262,422.87 in Stock
athenahealth Inc. (NASDAQ:ATHN) SVP Daniel P. Haley sold 2,109 shares of the firm’s stock in a transaction on Monday, October 3rd. The stock was sold at an average price of $124.43, for a total transaction of $262,422.87. Following the transaction, the senior vice president now directly owns 3,195 shares in the company, valued at $397,553.85. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Shares of athenahealth Inc. (NASDAQ:ATHN) opened at 125.97 on Monday. The stock’s 50 day moving average is $123.18 and its 200-day moving average is $129.87. The stock has a market capitalization of $4.96 billion, a P/E ratio of 463.12 and a beta of 1.28. athenahealth Inc. has a one year low of $114.59 and a one year high of $170.42.
athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, July 21st. The company reported $0.34 EPS for the quarter, missing the consensus estimate of $0.42 by $0.08. The firm had revenue of $261.90 million for the quarter, compared to the consensus estimate of $274.07 million. athenahealth had a return on equity of 5.16% and a net margin of 1.06%. On average, equities research analysts expect that athenahealth Inc. will post $1.77 EPS for the current year.
Several research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of athenahealth from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 12th. Morgan Stanley lowered their price objective on shares of athenahealth from $186.00 to $153.00 and set an “overweight” rating on the stock in a research report on Monday, July 25th. FBR & Co lowered their price objective on shares of athenahealth from $145.00 to $140.00 and set a “market perform” rating on the stock in a research report on Friday, July 22nd. Canaccord Genuity reissued a “hold” rating and set a $142.00 price objective on shares of athenahealth in a research report on Wednesday, June 29th. Finally, Leerink Swann reissued a “hold” rating on shares of athenahealth in a research report on Thursday, June 16th. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and eight have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $149.58.
Institutional investors have recently added to or reduced their stakes in the company. Advisor Group Inc. purchased a new position in athenahealth during the second quarter valued at approximately $118,000. FineMark National Bank & Trust raised its position in athenahealth by 4.5% in the second quarter. FineMark National Bank & Trust now owns 944 shares of the company’s stock valued at $130,000 after buying an additional 41 shares in the last quarter. KBC Group NV purchased a new position in athenahealth during the second quarter valued at approximately $135,000. Societe Generale purchased a new position in athenahealth during the second quarter valued at approximately $176,000. Finally, SG Americas Securities LLC raised its position in athenahealth by 27.7% in the second quarter. SG Americas Securities LLC now owns 1,277 shares of the company’s stock valued at $176,000 after buying an additional 277 shares in the last quarter.
athenahealth Company Profile
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.